Clinical Trial: Multi-target TMS for Schizophrenia Negative Symptoms

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559084) titled 'Multi-target TMS for Schizophrenia Negative Symptoms' on April 09.

Brief Summary: This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the left dorsolateral prefrontal cortex (L-DLPFC), left inferior parietal lobule (L-IPL), and right orbitofrontal cortex (R-OFC) for negative symptoms of schizophrenia.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: SCHIZOPHRENIA 1 (Disorder)

Intervention: DEVICE: repetitive transcranial magnetic stimulation (rTMS)

Repetitive transcranial magnetic stimulation (rTMS) is a recently developed neuromodulation...